Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Single-Cell DNA Sequencing Reveals an Evolutionary Pattern of CHIP in Transplant Eligible Multiple Myeloma Patients.
Borsi E, Vigliotta I, Poletti A, Mazzocchetti G, Solli V, Zazzeroni L, Martello M, Armuzzi S, Taurisano B, Kanapari A, Pistis I, Zamagni E, Pantani L, Rocchi S, Mancuso K, Tacchetti P, Rizzello I, Rizzi S, Dan E, Sinigaglia B, Cavo M, Terragna C. Borsi E, et al. Among authors: dan e. Cells. 2024 Apr 9;13(8):657. doi: 10.3390/cells13080657. Cells. 2024. PMID: 38667272 Free PMC article.
The addition of plerixafor is safe and allows adequate PBSC collection in multiple myeloma and lymphoma patients poor mobilizers after chemotherapy and G-CSF.
D'Addio A, Curti A, Worel N, Douglas K, Motta MR, Rizzi S, Dan E, Taioli S, Giudice V, Agis H, Kopetzky G, Soutar R, Casadei B, Baccarani M, Lemoli RM. D'Addio A, et al. Among authors: dan e. Bone Marrow Transplant. 2011 Mar;46(3):356-63. doi: 10.1038/bmt.2010.128. Epub 2010 May 31. Bone Marrow Transplant. 2011. PMID: 20577218
Larger Size of Donor Alloreactive NK Cell Repertoire Correlates with Better Response to NK Cell Immunotherapy in Elderly Acute Myeloid Leukemia Patients.
Curti A, Ruggeri L, Parisi S, Bontadini A, Dan E, Motta MR, Rizzi S, Trabanelli S, Ocadlikova D, Lecciso M, Giudice V, Fruet F, Urbani E, Papayannidis C, Martinelli G, Bandini G, Bonifazi F, Lewis RE, Cavo M, Velardi A, Lemoli RM. Curti A, et al. Among authors: dan e. Clin Cancer Res. 2016 Apr 15;22(8):1914-21. doi: 10.1158/1078-0432.CCR-15-1604. Epub 2016 Jan 19. Clin Cancer Res. 2016. PMID: 26787753 Free article. Clinical Trial.
Low-Dose Anti-T Lymphoglobulin as Prophylaxis for Graft-versus-Host Disease in Unrelated Donor Transplantations for Acute Leukemias and Myelodysplastic Syndromes.
Bonifazi F, Olivieri J, Sessa M, Dan E, Sinigaglia B, Rizzi S, Motta MR, Bontadini A, Ulbar F, Giudice V, Papayannidis C, Curti A, Chiereghin A, Lazzarotto T, Cavo M, Arpinati M. Bonifazi F, et al. Among authors: dan e. Biol Blood Marrow Transplant. 2018 Dec;24(12):2450-2458. doi: 10.1016/j.bbmt.2018.07.011. Epub 2018 Jul 17. Biol Blood Marrow Transplant. 2018. PMID: 30026107 Free article.
Intrabone transplant provides full stemness of cord blood stem cells with fast hematopoietic recovery and low GVHD rate: results from a prospective study.
Bonifazi F, Dan E, Labopin M, Sessa M, Guadagnuolo V, Ferioli M, Rizzi S, De Carolis S, Sinigaglia B, Motta MR, Bontadini A, Giudice V, Martinelli G, Arpinati M, Cavo M, Bonafé M, Storci G. Bonifazi F, et al. Among authors: dan e. Bone Marrow Transplant. 2019 May;54(5):717-725. doi: 10.1038/s41409-018-0335-x. Epub 2018 Sep 19. Bone Marrow Transplant. 2019. PMID: 30232415 Free PMC article. Clinical Trial.
The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma.
Tolomelli G, Mancuso K, Tacchetti P, Patriarca F, Galli M, Pantani L, Zannetti B, Motta MR, Rizzi S, Dan E, Sinigaglia B, Giudice V, Olmo A, Arpinati M, Chirumbolo G, Fanin R, Lewis RE, Paris L, Bonifazi F, Cavo M, Curti A, Lemoli RM. Tolomelli G, et al. Among authors: dan e. Bone Marrow Transplant. 2020 May;55(5):946-954. doi: 10.1038/s41409-019-0756-1. Epub 2019 Nov 25. Bone Marrow Transplant. 2020. PMID: 31768009
Low doses ATLG as GvHD prophylaxis in allogeneic hematopoietic stem cell transplantation for lymphomas.
Bonifazi F, Defrancesco I, Olivieri J, Barbato F, Lopedote P, Dicataldo M, Sessa M, Dan E, Sinigaglia B, Zazzeroni L, Rizzi S, Tassi C, Casadei B, Zinzani PL, Arpinati M. Bonifazi F, et al. Among authors: dan e. Bone Marrow Transplant. 2021 Sep;56(9):2295-2298. doi: 10.1038/s41409-021-01359-x. Epub 2021 Jun 9. Bone Marrow Transplant. 2021. PMID: 34108674 No abstract available.
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters.
Parisi S, Ruggeri L, Dan E, Rizzi S, Sinigaglia B, Ocadlikova D, Bontadini A, Giudice V, Urbani E, Ciardelli S, Sartor C, Cristiano G, Nanni J, Zannoni L, Chirumbolo G, Arpinati M, Lewis RE, Bonifazi F, Marconi G, Martinelli G, Papayannidis C, Paolini S, Velardi A, Cavo M, Lemoli RM, Curti A. Parisi S, et al. Among authors: dan e. Front Immunol. 2022 Jan 31;12:804988. doi: 10.3389/fimmu.2021.804988. eCollection 2021. Front Immunol. 2022. PMID: 35173709 Free PMC article.
Polo-like kinase-1, Aurora kinase A and WEE1 kinase are promising druggable targets in CML cells displaying BCR::ABL1-independent resistance to tyrosine kinase inhibitors.
Mancini M, De Santis S, Monaldi C, Castagnetti F, Lonetti A, Bruno S, Dan E, Sinigaglia B, Rosti G, Cavo M, Gugliotta G, Soverini S. Mancini M, et al. Among authors: dan e. Front Oncol. 2022 Aug 5;12:901132. doi: 10.3389/fonc.2022.901132. eCollection 2022. Front Oncol. 2022. PMID: 35992847 Free PMC article.
Case report: Senescence as mechanism of resistance to Pembrolizumab in a Lymphoma patient who failed CD19-Targeted CAR-T cell therapy.
De Matteis S, Casadei B, Lolli G, Dicataldo M, Barbato F, Dan E, Paccagnella A, Sinigaglia B, Bertuzzi C, Arcari A, Zazzeroni L, Bernuzzi P, Laprovitera N, Storci G, Bertuccio SN, Ferracin M, Bonafè M, Zinzani PL, Bonifazi F. De Matteis S, et al. Among authors: dan e. Front Immunol. 2022 Oct 6;13:994731. doi: 10.3389/fimmu.2022.994731. eCollection 2022. Front Immunol. 2022. PMID: 36275688 Free PMC article.
47 results